72 results
Page 2 of 4
424B5
sx3c5tgh
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
wd9u 23hrni
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
uocp6
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
epfzt
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
y80iqsusmb5ps0j51d20
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-10.1
cne020626ku42pym
26 Jun 20
Departure of Directors or Certain Officers
4:06pm
425
trirnlpc1h8fqpt1b 09
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
0l7v2uts
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
dggej 7u4w0h7hsi
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
mn2lr8u
24 Jun 20
Business combination disclosure
4:03pm
425
9a67 978crtd
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.4
wqeg2o j8kfu
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
3yie9ha
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm